List view / Grid view
The European Commission has approved Pluvicto® as the first targeted…
The European Commission has approved Pluvicto® as the first targeted radioligand therapy for advanced prostate cancer, based on significant results from the Phase III VISION trial.
In a formal ceremony, the new headquarters for Novartis has…
In a formal ceremony, the new headquarters for Novartis has been opened in White City, London, in close proximity to Imperial College London’s research campus.
The ABPI’s board has unanimously appointed Dr Richard Torbett as…
The ABPI’s board has unanimously appointed Dr Richard Torbett as Chief Executive, commencing 1 January 2020.
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the…
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
